OR24 Glucocorticoid Synthesis, Action and Modulation

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Adrenal HPA Axis-Basic/Translational
Sunday, April 3, 2016: 11:45 AM-1:15 PM
Room 156 (BCEC)
Chairs:
Wiebke Arlt, MD, DSc, FRCP, FMedSci, University of Birmingham, Birmingham, United Kingdom and George P. Chrousos, MD, PhD, University of Athens Medical School, Athens, Greece

Disclosures:
WA: Consultant, Diurnal. Disclosure Not Provided: GPC, LSK
11:45 AM
Mahita Kadmiel, Signal Transduction Laboratory, NIEHS/NIH, Durham, NC, Sivapriya Ramamoorthy, MS, PhD, Lab of Signal Transduction, NIEHS, Research Triangle Park, NC, Julie F Foley, Cellular & Molecular Pathology Branch, National Institute of Environmental Health Sciences, RTP, NC and John A Cidlowski, PhD, Laboratory of Signal Transduction, NIEHS/NIH, Research Triangle Pk, NC
12:00 PM
Eirini Meimaridou, DR, Centre for Endocrinology, William Harvey research Institute, Queen Mary University of London, London, United Kingdom, Michelle Goldsworthy Goldsworthy, DR, Diabetes Group, Medical Research Council (MRC) Harwell, Oxfordshire, Vasileios Chortis, MD, MRCP, Centre for Endocrinology, Diabetes and Metabolism, School of Clinical and and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom, Terpsichori Fragoulis, William Harvey Research Institute, Paul A Foster, PhD, Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom, Wiebke Arlt, MD, DSc, FRCP, FMedSci, Centre for Endocrinology, Diabetes and Metabolism, School of Clinical & Experimental Medicine, University of Birmingham, Birmingham, United Kingdom, Roger D Cox, PhD, MRC Harwell Mammalian Genetics Unit, United Kingdom and Louise A Metherell, PhD, Centre for Endocrinology, William Harvey Research Institute, John Vane Science Centre, Queen Mary, University of London, London, United Kingdom
12:15 PM
Francesca Spiga1, Zidong Zaho1, Julia Gjerstad1, Xixi Feng2, Felix Hausch2 and Stafford Louis Lightman1, (1)University of Bristol, Bristol, United Kingdom
(2)Max Planck Institute of Psychiatry, Munich, Germany
12:30 PM
Rucha Patel, PhD1, Ricky Tsai1, Arturo Orellana2 and Carolyn L Cummins1, (1)Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada
(2)Chemistry, York University, Toronto, ON, Canada
12:45 PM
Tracy Choi Sze Mak1, Dawn EW Livingstone, PhD2, Brian R Walker, BSc, MBChB, MD, FRSE3 and Ruth Andrew, PhD2, (1)Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh, United Kingdom
(2)Endocrinology, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom
(3)University/BHF Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom
1:00 PM
Camilla AM Glad, MSc, PhD1, Johanna C Andersson-Assarsson, MSc, PhD2, Ragnhildur Bergthorsdottir, MD, PhD3, Oskar Ragnarsson, MD, PhD3 and Gudmundur Johannsson, MD, PhD3, (1)Dept of Endocrinology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
(2)Dept of Molecular and Clinical Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
(3)Dept of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire